Abstract
Protein microarrays allow the simultaneous determination of a variety of parameters in parallel from minute amounts of sample, which allows for a high throughput analysis of translated gene functions. This article provides a wide and updated coverage of topics such as the complexity of this technology as compared to the gene expression technology, classification of protein microarrays, surface chemistry, detection methods, capture agents, experimental design, data analysis, standards, databases and interactions. The role of protein microarrays for the identification of cancer biomarkers in tissue and serum has also been elucidated. There are currently no guidelines on how to standardize these assays for biomarker discovery. Issues of sensitivity, specificity, difficulty in maintaining the native state of the protein upon surface immobilization, and limitations of the current arrays represent challenges that need to be overcome, and should be understood by those who are employing this parallel multiplexed technology in order to be able to achieve high throughput applications and minimize the occurrence of false positive and negative results.
Keywords: Classification, surface chemistry, detection, capture agents, standards, data analysis
Current Genomics
Title: Expression Microarray Proteomics and the Search for Cancer Biomarkers
Volume: 7 Issue: 7
Author(s): Farid E. Ahmed
Affiliation:
Keywords: Classification, surface chemistry, detection, capture agents, standards, data analysis
Abstract: Protein microarrays allow the simultaneous determination of a variety of parameters in parallel from minute amounts of sample, which allows for a high throughput analysis of translated gene functions. This article provides a wide and updated coverage of topics such as the complexity of this technology as compared to the gene expression technology, classification of protein microarrays, surface chemistry, detection methods, capture agents, experimental design, data analysis, standards, databases and interactions. The role of protein microarrays for the identification of cancer biomarkers in tissue and serum has also been elucidated. There are currently no guidelines on how to standardize these assays for biomarker discovery. Issues of sensitivity, specificity, difficulty in maintaining the native state of the protein upon surface immobilization, and limitations of the current arrays represent challenges that need to be overcome, and should be understood by those who are employing this parallel multiplexed technology in order to be able to achieve high throughput applications and minimize the occurrence of false positive and negative results.
Export Options
About this article
Cite this article as:
Ahmed E. Farid, Expression Microarray Proteomics and the Search for Cancer Biomarkers, Current Genomics 2006; 7 (7) . https://dx.doi.org/10.2174/138920206779116792
DOI https://dx.doi.org/10.2174/138920206779116792 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics
Current Cancer Drug Targets Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles
Current Pharmaceutical Biotechnology The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery Schistosoma mansoni Changes the Activity of Phase II Drug-Metabolizing Enzymes: Role of Praziquantel as Antibilharzial Drug
Drug Metabolism Letters Targeted Drug Delivery System for Platinum-based Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy Eosinophils in Cancer: Favourable or Unfavourable?
Current Medicinal Chemistry Aqueous Extracts of Selected Potentilla Species Modulate Biological Activity of Human Normal Colon Cells
Current Drug Targets Management of Inflammatory Bowel Disease Patients with a Cancer History
Current Drug Targets Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma
MicroRNA Facile Synthesis of Anticancer Drug NCX 4040 in Mild Conditions
Letters in Organic Chemistry Overview of SLC22A and SLCO Families of Drug Uptake Transporters in the Context of Cancer Treatments
Current Drug Metabolism The Production of Solid Dosage Forms from Non-Degradable Polymers
Current Pharmaceutical Design Nanotechnological Advances in the Treatment of Epilepsy
CNS & Neurological Disorders - Drug Targets Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick
Mini-Reviews in Medicinal Chemistry Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
Current Pharmaceutical Design The Role of Oxidative Stress in Smoking-Related Diseases
Mini-Reviews in Organic Chemistry